Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EDIT: Tobramycin Inhalation Powder in Cystic Fibrosis
NCT00918957Phase 3Completed
- Sponsor
- Novartis
- Start
- Jun 2009
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of tobramycin in cystic fibrosis (CF), sponsored by Novartis. Started Jun 2009; status: completed.
02
Drugs
tobramycin
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT00918957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00918957.